Potential of tetracycline resistance proteins to evolve tigecycline resistance

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 2, 2016, Pages 789-796

  Linkevicius, Marius ^a   Sandegren, Linus ^a   Andersson, Dan I ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; LEUCINE; MINOCYCLINE; MUTANT PROTEIN; PROTEIN TET(A); PROTEIN TET(M); PROTEIN TET(X); RIBOSOME PROTEIN; TETRACYCLINE; TIGECYCLINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; MEMBRANE PROTEIN;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; GENE MUTATION; HORIZONTAL GENE TRANSFER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; ANALOGS AND DERIVATIVES; DRUG EFFECTS; GENETICS; MICROBIAL SENSITIVITY TEST;

ANTI-BACTERIAL AGENTS; ESCHERICHIA COLI; MEMBRANE PROTEINS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; TETRACYCLINE RESISTANCE;

EID: 84957880449     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02465-15     Document Type: Article

References (42)

1. Noskin GA. 2005. Tigecycline: a new glycylcycline for treatment of serious infections. Clin Infect Dis 41(suppl 5):S303-S314.
2. Petersen PJ, Jacobus NV, Weiss WJ, Sum PE, Testa RT. 1999. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936). Antimicrob Agents Chemother 43:738-744.
3. Sum PE, Petersen P. 1999. Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936. Bioorg Med Chem Lett 9:1459-1462. http://dx.doi.org/10.1016/S0960-894X(99)00216-4.
4. 2+ cleavage of 16S rRNA. J Antimicrob Chemother 53:592-599. http://dx.doi.org/10.1093/jac/dkh125.
5. Olson MW, Ruzin A, Feyfant E, Rush TS, O'Connell J, Bradford PA. 2006. Functional, biophysical, and structural bases for antibacterial activity of tigecycline. Antimicrob Agents Chemother 50:2156-2166. http://dx.doi.org/10.1128/AAC.01499-05.
6. Jenner L, Starosta AL, Terry DS, Mikolajka A, Filonava L, Yusupov M, Blanchard SC, Wilson DN, Yusupova G. 2013. Structural basis for potent inhibitory activity of the antibiotic tigecycline during protein synthesis. Proc Natl Acad Sci USA110:3812-3816. http://dx.doi.org/10.1073/pnas.1216691110.
7. Chopra I, Roberts M. 2001. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev 65:232-260. http://dx.doi.org/10.1128/MMBR.65.2.232-260.2001.
8. Hirata T, Saito A, Nishino K, Tamura N, Yamaguchi A. 2004. Effects of efflux transporter genes on susceptibility of Escherichia coli to tigecycline (GAR-936). Antimicrob Agents Chemother 48:2179-2184. http://dx.doi.org/10.1128/AAC.48.6.2179-2184.2004.
9. Thaker M, Spanogiannopoulos P, Wright GD. 2010. The tetracycline resistome. Cell Mol Life Sci 67:419-431. http://dx.doi.org/10.1007/s00018-009-0172-6.
10. Dönhöfer A, Franckenberg S, Wickles S, Berninghausen O, Beckmann R, Wilson DN. 2012. Structural basis for TetM-mediated tetracycline resistance. Proc Natl Acad Sci U S A 109:16900-16905. http://dx.doi.org/10.1073/pnas.1208037109.
11. Arenz S, Nguyen F, Beckmann R, Wilson DN. 2015. Cryo-EM structure of the tetracycline resistance protein TetM in complex with a translating ribosome at 3.9-Å resolution. Proc Natl Acad Sci U S A 112:5401-5406. http://dx.doi.org/10.1073/pnas.1501775112.
12. Guiney DG, Hasegawa P, Davis CE. 1984. Expression in Escherichia coli of cryptic tetracycline resistance genes from Bacteroides R plasmids. Plasmid 11:248-252. http://dx.doi.org/10.1016/0147-619X(84)90031-3.
13. Yang W, Moore IF, Koteva KP, Bareich DC, Hughes DW, Wright GD. 2004. TetX is a flavin-dependent monooxygenase conferring resistance to tetracycline antibiotics. J Biol Chem 279:52346-52352. http://dx.doi.org/10.1074/jbc.M409573200.
14. Moore IF, Hughes DW, Wright GD. 2005. Tigecycline is modified by the flavin-dependent monooxygenase TetX. Biochemistry 44:11829-11835. http://dx.doi.org/10.1021/bi0506066.
15. Leski TA, Bangura U, Jimmy DH, Ansumana R, Lizewski SE, Stenger DA, Taitt CR, Vora GJ. 2013. Multidrug-resistant tet(X)-containing hospital isolates in Sierra Leone. Int J Antimicrob Agents 42:83-86. http://dx.doi.org/10.1016/j.ijantimicag.2013.04.014.
16. Ruzin A, Visalli MA, Keeney D, Bradford PA. 2005. Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniae. Antimicrob Agents Chemother 49:1017-1022. http://dx.doi.org/10.1128/AAC.49.3.1017-1022.2005.
17. Keeney D, Ruzin A, Bradford PA. 2007. RamA, a transcriptional regulator, and AcrAB, an RND-type efflux pump, are associated with decreased susceptibility to tigecycline in Enterobacter cloacae. Microb Drug Resist 13:1-6. http://dx.doi.org/10.1089/mdr.2006.9990.
18. Keeney D, Ruzin A, McAleese F, Murphy E, Bradford PA. 2008. MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli. J Antimicrob Chemother 61:46-53.
19. Hentschke M, Christner M, Sobottka I, Aepfelbacher M, Rohde H. 2010. Combined ramR mutation and presence of a Tn1721-associated tet(A) variant in a clinical isolate of Salmonella enterica serovar Hadar resistant to tigecycline. Antimicrob Agents Chemother 54:1319-1322. http://dx.doi.org/10.1128/AAC.00993-09.
20. Veleba M, De Majumdar S, Hornsey M, Woodford N, Schneiders T. 2013. Genetic characterization of tigecycline resistance in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. J Antimicrob Chemother 68:1011-1018. http://dx.doi.org/10.1093/jac/dks530.
21. Barlow M, Hall BG. 2002. Predicting evolutionary potential: in vitro evolution accurately reproduces natural evolution of the TEM β-lactamase. Genetics 160:823-832.
22. Weinreich DM, Delaney NF, Depristo MA, Hartl DL. 2006. Darwinian evolution can follow only very few mutational paths to fitter proteins. Science 312:111-114. http://dx.doi.org/10.1126/science.1123539.
23. Schenk MF, Witte S, Salverda MLM, Koopmanschap B, Krug J, de Visser JAGM. 2015. Role of pleiotropy during adaptation of TEM-1 β-lactamase to two novel antibiotics. Evol Appl 8:248-260. http://dx.doi.org/10.1111/eva.12200.
24. Tuckman M, Petersen PJ, Projan SJ. 2000. Mutations in the interdomain loop region of the tetA(A) tetracycline resistance gene increase efflux of minocycline and glycylcyclines. Microb Drug Resist 6:277-282. http://dx.doi.org/10.1089/mdr.2000.6.277.
25. Sandegren L, Linkevicius M, Lytsy B, Melhus Å, Andersson DI. 2012. Transfer of an Escherichia coli ST131 multiresistance cassette has created a Klebsiella pneumoniae-specific plasmid associated with a major nosocomial outbreak. J Antimicrob Chemother 67:74-83. http://dx.doi.org/10.1093/jac/dkr405.
26. Wang W, Guo Q, Xu X, Sheng Z-K, Ye X, Wang M. 2014. High-level tetracycline resistance mediated by efflux pumps Tet(A) and Tet(A)-1 with two start codons. J Med Microbiol 63:1454-1459. http://dx.doi.org/10.1099/jmm.0.078063-0.
27. BAD promoter. J Bacteriol 177:4121-4130.
28. Daniels DW, Bertrand KP. 1985. Promoter mutations affecting divergent transcription in the Tn10 tetracycline resistance determinant. J Mol Biol 184:599-610. http://dx.doi.org/10.1016/0022-2836(85)90306-7.
29. Rasila TS, Pajunen MI, Savilahti H. 2009. Critical evaluation of random mutagenesis by error-prone polymerase chain reaction protocols, Escherichia coli mutator strain, and hydroxylamine treatment. Anal Biochem 388:71-80. http://dx.doi.org/10.1016/j.ab.2009.02.008.
30. Lind PA, Tobin C, Berg OG, Kurland CG, Andersson DI. 2010. Compensatory gene amplification restores fitness after interspecies gene replacements. Mol Microbiol 75:1078-1089. http://dx.doi.org/10.1111/j.1365-2958.2009.07030.x.
31. Hemsley A, Arnheim N, Toney MD, Cortopassi G, Galas DJ. 1989. A simple method for site-directed mutagenesis using the polymerase chain reaction. Nucleic Acids Res 17:6545-6551. http://dx.doi.org/10.1093/nar/17.16.6545.
32. Brown D, Canton R, MacGowan AP. 2006. EUCAST technical note on tigecycline. Clin Microbiol Infect 12:1147-1149. http://dx.doi.org/10.1111/j.1469-0691.2006.01578.x.
33. U.S. Food and Drug Administration, Center for Drug Evaluation and Research. 2013. Tygacil NDA no. 021821 label information. Wyeth Pharmaceuticals, Philadelphia, PA. http://www.accessdata.fda.gov/drugsatfda-docs/label/2013/021821s026s031lbl.pdf.
34. Fyfe C, Sutcliffe JA, Grossman TH. 2013. Susceptibility of tetracyclines to Tet(A) resistance is independent of interdomain loop sequence. Antimicrob Agents Chemother 57:2430-2431. http://dx.doi.org/10.1128/AAC.00393-13.
35. + antiporter. J Biol Chem 276:20330-20339. http://dx.doi.org/10.1074/jbc.M007993200
36. McNicholas P, Chopra I, Rothstein DM. 1992. Genetic analysis of the tetA(C) gene on plasmid pBR322. J Bacteriol 174:7926-7933.
37. McNicholas P, McGlynn M, Guay GG, Rothstein DM. 1995. Genetic analysis suggests functional interactions between the N- and C-terminal domains of the TetA(C) efflux pump encoded by pBR322. J Bacteriol 177:5355-5357.
38. Guay GG, Tuckman M, Rothstein DM. 1994. Mutations in the tetA(B) gene that cause a change in substrate specificity of the tetracycline efflux pump. Antimicrob Agents Chemother 38:857-860. http://dx.doi.org/10.1128/AAC.38.4.857.
39. + antiporter Tet(K) of Staphylococcus aureus. FEBS Lett 419:211-214. http://dx.doi.org/10.1016/S0014-5793(97)01457-9.
40. Li W Atkinson GC, Thakor NS, Allas U, Lu C-C, Chan K-Y, Tenson T, Schulten K, Wilson KS, Hauryliuk V, Frank J. 2013. Mechanism of tetracycline resistance by ribosomal protection protein Tet(O). Nat Commun 4:1477. http://dx.doi.org/10.1038/ncomms2470.
41. Volkers G, Damas JM, Palm GJ, Panjikar S, Soares CM, Hinrichs W. 2013. Putative dioxygen-binding sites and recognition of tigecycline and minocycline in the tetracycline-degrading monooxygenase TetX. Acta Crystallogr D Biol Crystallogr 69:1758-1767. http://dx.doi.org/10.1107/S0907444913013802.
42. Walkiewicz K, Benitez Cardenas AS, Sun C, Bacorn C, Saxer G, Shamoo Y. 2012. Small changes in enzyme function can lead to surprisingly large fitness effects during adaptive evolution of antibiotic resistance. Proc Natl Acad Sci U S A 109:21408-21413. http://dx.doi.org/10.1073/pnas.1209335110.